- Home
- CTSO vs THCH Comparison
CTSO vs THCH Comparison
Compare CTSO & THCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTSO
- THCH
- Stock Information
- Founded
- CTSO 1997
- THCH 2018
- Country
- CTSO United States
- THCH China
- Employees
- CTSO N/A
- THCH N/A
- Industry
- CTSO Medical/Dental Instruments
- THCH Blank Checks
- Sector
- CTSO Health Care
- THCH Finance
- Exchange
- CTSO Nasdaq
- THCH Nasdaq
- Market Cap
- CTSO 72.8M
- THCH 84.8M
- IPO Year
- CTSO N/A
- THCH N/A
- Fundamental
- Price
- CTSO $0.89
- THCH $2.60
- Analyst Decision
- CTSO Buy
- THCH
- Analyst Count
- CTSO 2
- THCH 0
- Target Price
- CTSO $5.50
- THCH N/A
- AVG Volume (30 Days)
- CTSO 351.0K
- THCH 12.6K
- Earning Date
- CTSO 08-07-2025
- THCH 08-26-2025
- Dividend Yield
- CTSO N/A
- THCH N/A
- EPS Growth
- CTSO N/A
- THCH N/A
- EPS
- CTSO N/A
- THCH N/A
- Revenue
- CTSO $36,107,520.00
- THCH $187,384,526.00
- Revenue This Year
- CTSO $11.15
- THCH N/A
- Revenue Next Year
- CTSO $21.39
- THCH N/A
- P/E Ratio
- CTSO N/A
- THCH N/A
- Revenue Growth
- CTSO 20.18
- THCH N/A
- 52 Week Low
- CTSO $0.71
- THCH $1.95
- 52 Week High
- CTSO $1.61
- THCH $5.15
- Technical
- Relative Strength Index (RSI)
- CTSO 41.50
- THCH 41.31
- Support Level
- CTSO $1.03
- THCH $2.47
- Resistance Level
- CTSO $1.19
- THCH $2.79
- Average True Range (ATR)
- CTSO 0.09
- THCH 0.25
- MACD
- CTSO 0.01
- THCH -0.01
- Stochastic Oscillator
- CTSO 27.21
- THCH 66.33
About CTSO Cytosorbents Corporation
CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.
About THCH TH International Limited Ordinary shares
TH International Ltd is the parent company of the franchise of Tim Hortons coffee shops and has the rights to operate Tim Hortons coffee shops in mainland China, Hong Kong, and Macau. Through the Tim Hortons brand, the firm offers freshly brewed coffee, tea, and other beverages, bakery & sides, and sandwiches. The Company operated under single reportable segment, Tim Hortons. The company's revenue is derived from its operations in the PRC.